{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:04:28Z","timestamp":1791266668807,"version":"4.1.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U23A20534"],"award-info":[{"award-number":["U23A20534"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Discov"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    c-Myc is broadly hyperactivated in colon cancer, yet the mechanisms sustaining its transcriptional activation remain elusive. Here we identify palmitic acid (PA) as a metabolite cue that activates c-Myc via dual palmitoylation-dependent pathways operating across tumor initiation and progression. In colitis models, PA-rich diets exacerbate inflammation and enrich MYC target programs without increasing\n                    <jats:italic>Myc<\/jats:italic>\n                    mRNA. Mechanistically, the palmitoyltransferase ZDHHC9, upregulated by IL-1\u03b2, directly palmitoylates c-Myc at C171, enhancing c-Myc\/MAX dimerization and transcriptional activity; genetic or pharmacologic inhibition diminishes c-Myc palmitoylation and target gene expression. During tumor progression, c-Myc transactivates FATP2, increasing PA uptake and reinforcing c-Myc palmitoylation, thereby establishing a feedforward loop and metabolic addiction to PA. Functionally, PA accelerates xenograft growth, whereas targeting ZDHHC9 and FATP2 inhibits c-Myc function to suppress tumor burden. These findings uncover metabolite-driven control of c-Myc through palmitoylation and highlight ZDHHC9\/FATP2 as actionable vulnerabilities for colon cancer treatment.\n                  <\/jats:p>","DOI":"10.1038\/s41421-026-00869-6","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T02:02:24Z","timestamp":1771293744000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Palmitic acid activates c-Myc via dual palmitoylation-dependent pathways to promote colon cancer"],"prefix":"10.1038","volume":"12","author":[{"given":"Wenxin","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuexin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaojun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejing","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meidan","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"869_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L., Miller, K. D., Wagle, N. S. & Jemal, A. Cancer statistics, 2023. Ca-Cancer J. Clin. 73, 17\u201348 (2023).","journal-title":"Ca-Cancer J. Clin."},{"key":"869_CR2","doi-asserted-by":"crossref","unstructured":"Dang, C. V. MYC on the path to cancer. Cell 149, 22\u201335 (2012).","DOI":"10.1016\/j.cell.2012.03.003"},{"key":"869_CR3","doi-asserted-by":"crossref","unstructured":"Ciclitira, P. J., Macartney, J. C. & Evan, G. Expression of c-myc in non-malignant and pre-malignant gastrointestinal disorders. J Pathol. 151, 293\u2013296 (1987).","DOI":"10.1002\/path.1711510409"},{"key":"869_CR4","doi-asserted-by":"crossref","unstructured":"Macpherson, A. J. et al. Increased expression of c-myc proto-oncogene in biopsies of ulcerative colitis and Crohn\u2019s colitis. Gut 33, 651\u2013656 (1992).","DOI":"10.1136\/gut.33.5.651"},{"key":"869_CR5","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1053\/j.gastro.2016.04.001","volume":"151","author":"R Yaeger","year":"2016","unstructured":"Yaeger, R. et al. Genomic alterations observed in colitis-associated cancers are distinct from those found in sporadic colorectal cancers and vary by type of inflammatory bowel disease. Gastroenterology 151, 278\u2013287 (2016).","journal-title":"Gastroenterology"},{"key":"869_CR6","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1093\/ibd\/izy057","volume":"24","author":"DJ Hartman","year":"2018","unstructured":"Hartman, D. J. et al. Distinct histopathologic and molecular alterations in inflammatory bowel disease-associated intestinal adenocarcinoma: amplification is common and associated with mucinous\/signet ring cell differentiation. Inflamm. Bowel Dis. 24, 1780\u20131790 (2018).","journal-title":"Inflamm. Bowel Dis."},{"key":"869_CR7","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nature11252","volume":"487","author":"DM Muzny","year":"2012","unstructured":"Muzny, D. M. et al. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330\u2013337 (2012).","journal-title":"Nature"},{"key":"869_CR8","doi-asserted-by":"crossref","unstructured":"Satoh, K. et al. Global metabolic reprogramming of colorectal cancer occurs at adenoma stage and is induced by MYC. Proc. Natl. Acad. Sci. USA 114, E7697\u2013E7706 (2017).","DOI":"10.1073\/pnas.1710366114"},{"key":"869_CR9","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.3390\/ijms20092340","volume":"20","author":"M Elbadawy","year":"2019","unstructured":"Elbadawy, M., Usui, T., Yamawaki, H. & Sasaki, K. Emerging roles of c-Myc in cancer stem cell-related signaling and resistance to cancer chemotherapy: A potential therapeutic target against colorectal cancer. Int J. Mol. Sci. 20, 2340 (2019).","journal-title":"Int J. Mol. Sci."},{"key":"869_CR10","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/s41575-019-0209-8","volume":"16","author":"SH Wong","year":"2019","unstructured":"Wong, S. H. & Yu, J. Gut microbiota in colorectal cancer: Mechanisms of action and clinical applications. Nat. Rev. Gastroenterol. Hepatol. 16, 690\u2013704 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"869_CR11","doi-asserted-by":"crossref","unstructured":"Cao, H. L. et al. Secondary bile acid-induced dysbiosis promotes intestinal carcinogenesis. Int. J. Cancer 140, 2545\u20132556 (2017).","DOI":"10.1002\/ijc.30643"},{"key":"869_CR12","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/nrgastro.2016.165","volume":"13","author":"SJD O\u2019Keefe","year":"2016","unstructured":"O\u2019Keefe, S. J. D. Diet, microorganisms and their metabolites, and colon cancer. Nat. Rev. Gastroenterol. Hepatol. 13, 691\u2013706 (2016).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"869_CR13","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1007\/s00018-019-03092-7","volume":"76","author":"S Fatima","year":"2019","unstructured":"Fatima, S. et al. Palmitic acid is an intracellular signaling molecule involved in disease development. Cell. Mol. Life Sci. 76, 2547\u20132557 (2019).","journal-title":"Cell. Mol. Life Sci."},{"key":"869_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s43018-023-00702-z","volume":"5","author":"FCE Vogel","year":"2024","unstructured":"Vogel, F. C. E., Chaves, A. B. & Schulze, A. Lipids as mediators of cancer progression and metastasis. Nat. Cancer 5, 16\u201329 (2024).","journal-title":"Nat. Cancer"},{"key":"869_CR15","doi-asserted-by":"crossref","unstructured":"Linder, M. E. & Jennings, B. C. Mechanism and function of DHHC S-acyltransferases. Biochem Soc. Trans. 41, 29\u201334 (2013).","DOI":"10.1042\/BST20120328"},{"key":"869_CR16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1021\/acs.chemrev.6b00750","volume":"118","author":"H Jiang","year":"2018","unstructured":"Jiang, H. et al. Protein lipidation: occurrence, mechanisms, biological functions, and enabling technologies. Chem. Rev. 118, 43\u2013112 (2018).","journal-title":"Chem. Rev."},{"key":"869_CR17","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2799-2","volume":"586","author":"MM Zhang","year":"2020","unstructured":"Zhang, M. M. et al. A STAT3 palmitoylation cycle promotes Th17 differentiation and colitis. Nature 586, 434\u2013439 (2020).","journal-title":"Nature"},{"key":"869_CR18","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/nchembio.2036","volume":"12","author":"P Chan","year":"2016","unstructured":"Chan, P. et al. Autopalmitoylation of TEAD proteins regulates transcriptional output of the Hippo pathway. Nat. Chem. Biol. 12, 282\u2013289 (2016).","journal-title":"Nat. Chem. Biol."},{"key":"869_CR19","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.str.2015.11.005","volume":"24","author":"CL Noland","year":"2016","unstructured":"Noland, C. L. et al. Palmitoylation of TEAD transcription factors is required for their stability and function in hippo pathway signaling. Structure 24, 179\u2013186 (2016).","journal-title":"Structure"},{"key":"869_CR20","doi-asserted-by":"crossref","unstructured":"Carta, G., Murru, E., Banni, S. & Manca, C. Palmitic acid: physiological role, metabolism and nutritional implications. Front. Physiol. 8, 902 (2017).","DOI":"10.3389\/fphys.2017.00902"},{"key":"869_CR21","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1158\/2159-8290.CD-20-0844","volume":"10","author":"SM Fendt","year":"2020","unstructured":"Fendt, S. M., Frezza, C. & Erez, A. Targeting metabolic plasticity and flexibility dynamics for cancer therapy. Cancer Discov. 10, 1797\u20131807 (2020).","journal-title":"Cancer Discov."},{"key":"869_CR22","unstructured":"Guinney, J. et al. The consensus molecular subtypes of colorectal cancer. Nat. Med. 21, 1350\u20131356 (2015)."},{"key":"869_CR23","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.cmet.2023.07.006","volume":"35","author":"Y Xiao","year":"2023","unstructured":"Xiao, Y. et al. Emerging therapies in cancer metabolism. Cell Metab. 35, 1283\u20131303 (2023).","journal-title":"Cell Metab."},{"key":"869_CR24","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/s41388-020-01553-z","volume":"40","author":"KB Singh","year":"2021","unstructured":"Singh, K. B., Hahm, E. R., Kim, S. H., Wendell, S. G. & Singh, S. V. A novel metabolic function of Myc in regulation of fatty acid synthesis in prostate cancer. Oncogene 40, 592\u2013602 (2021).","journal-title":"Oncogene"},{"key":"869_CR25","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.cmet.2019.07.012","volume":"30","author":"AM Gouw","year":"2019","unstructured":"Gouw, A. M. et al. The MYC oncogene cooperates with sterol-regulated element-binding protein to regulate lipogenesis essential for neoplastic growth. Cell Metab. 30, 556\u2013572 (2019).","journal-title":"Cell Metab."},{"key":"869_CR26","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41392-020-00235-2","volume":"5","author":"Y Dong","year":"2020","unstructured":"Dong, Y., Tu, R., Liu, H. & Qing, G. Regulation of cancer cell metabolism: oncogenic MYC in the driver\u2019s seat. Signal Transduct. Target Ther. 5, 124 (2020).","journal-title":"Signal Transduct. Target Ther."},{"key":"869_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31331-2","volume":"13","author":"L Tao","year":"2022","unstructured":"Tao, L. et al. MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastoma. Nat. Commun. 13, 3728 (2022).","journal-title":"Nat. Commun."},{"key":"869_CR28","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/nature13398","volume":"514","author":"MD Schulz","year":"2014","unstructured":"Schulz, M. D. et al. High-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity. Nature 514, 508\u2013512 (2014).","journal-title":"Nature"},{"key":"869_CR29","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1053\/j.gastro.2021.08.041","volume":"162","author":"J Yang","year":"2022","unstructured":"Yang, J. et al. High-fat diet promotes colorectal tumorigenesis through modulating gut microbiota and metabolites. Gastroenterology 162, 135\u2013149 (2022).","journal-title":"Gastroenterology"},{"key":"869_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109212","volume":"35","author":"MD Mana","year":"2021","unstructured":"Mana, M. D. et al. High-fat diet-activated fatty acid oxidation mediates intestinal stemness and tumorigenicity. Cell Rep. 35, 109212 (2021).","journal-title":"Cell Rep."},{"key":"869_CR31","doi-asserted-by":"crossref","unstructured":"Bai, Y. et al. Shaping immune landscape of colorectal cancer by cholesterol metabolites. EMBO Mol. Med. 16, 334\u2013360 (2024).","DOI":"10.1038\/s44321-023-00015-9"},{"key":"869_CR32","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.chembiol.2020.09.001","volume":"28","author":"L Boike","year":"2021","unstructured":"Boike, L. et al. Discovery of a functional covalent ligand targeting an intrinsically disordered cysteine within MYC. Cell Chem. Biol. 28, 4\u201313 (2021).","journal-title":"Cell Chem. Biol."},{"key":"869_CR33","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10350","volume":"476","author":"R Possemato","year":"2011","unstructured":"Possemato, R. et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 476, 346\u2013350 (2011).","journal-title":"Nature"},{"key":"869_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26180-4","volume":"12","author":"Z Zhang","year":"2021","unstructured":"Zhang, Z. et al. DHHC9-mediated GLUT1 S-palmitoylation promotes glioblastoma glycolysis and tumorigenesis. Nat. Commun. 12, 5872 (2021).","journal-title":"Nat. Commun."},{"key":"869_CR35","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1128\/MCB.01248-13","volume":"34","author":"E Young","year":"2014","unstructured":"Young, E. et al. Regulation of Ras localization and cell transformation by evolutionarily conserved palmitoyltransferases. Mol. Cell Biol. 34, 374\u2013385 (2014).","journal-title":"Mol. Cell Biol."},{"key":"869_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114567","volume":"161","author":"Z Lin","year":"2023","unstructured":"Lin, Z. et al. Targeting ZDHHC9 potentiates anti-programmed death-ligand 1 immunotherapy of pancreatic cancer by modifying the tumor microenvironment. Biomed. Pharmacother. 161, 114567 (2023).","journal-title":"Biomed. Pharmacother."},{"key":"869_CR37","doi-asserted-by":"crossref","unstructured":"Yang, Y. et al. Palmitoylation stabilizes PD-L1 to promote breast tumor growth. Cell Res. 29, 83\u201386 (2019).","DOI":"10.1038\/s41422-018-0124-5"},{"key":"869_CR38","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/leu.2015.293","volume":"30","author":"P Liu","year":"2016","unstructured":"Liu, P. et al. Palmitoylacyltransferase Zdhhc9 inactivation mitigates leukemogenic potential of oncogenic Nras. Leukemia 30, 1225\u20131228 (2016).","journal-title":"Leukemia"},{"key":"869_CR39","doi-asserted-by":"crossref","unstructured":"Ren, J. G. et al. RAB27B controls palmitoylation-dependent NRAS trafficking and signaling in myeloid leukemia. J. Clin. Invest. 133, e165510 (2023).","DOI":"10.1172\/JCI165510"},{"key":"869_CR40","doi-asserted-by":"publisher","first-page":"24899","DOI":"10.1074\/jbc.M804308200","volume":"283","author":"H Sakiyama","year":"2008","unstructured":"Sakiyama, H. et al. Regulation of nuclear import\/export of carbohydrate response element-binding protein (ChREBP): Interaction of an alpha-helix of ChREBP with the 14-3-3 proteins and regulation by phosphorylation. J. Biol. Chem. 283, 24899\u201324908 (2008).","journal-title":"J. Biol. Chem."},{"key":"869_CR41","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.2337\/db10-0452","volume":"60","author":"C Guinez","year":"2011","unstructured":"Guinez, C. et al. O-GlcNAcylation increases ChREBP protein content and transcriptional activity in the liver. Diabetes 60, 1399\u20131413 (2011).","journal-title":"Diabetes"},{"key":"869_CR42","doi-asserted-by":"publisher","first-page":"4316","DOI":"10.1172\/JCI41624","volume":"120","author":"J Bricambert","year":"2010","unstructured":"Bricambert, J., Miranda, J., Benhamed, F., Postic, J. G. C. & Dentin, R. Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice. J. Clin. Invest 120, 4316\u20134331 (2010).","journal-title":"J. Clin. Invest"},{"key":"869_CR43","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1053\/j.gastro.2021.10.035","volume":"162","author":"SC Shah","year":"2022","unstructured":"Shah, S. C. & Itzkowitz, S. H. Colorectal cancer in inflammatory bowel disease: Mechanisms and management. Gastroenterology 162, 715\u2013730 (2022).","journal-title":"Gastroenterology"},{"key":"869_CR44","doi-asserted-by":"crossref","unstructured":"Wijnands, A. M., Mahmoud, R., Lutgens, M. W. M. D. & Oldenburg, B. Surveillance and management of colorectal dysplasia and cancer in inflammatory bowel disease: Current practice and future perspectives. Eur. J. Intern. Med. 93, 35\u201341 (2021).","DOI":"10.1016\/j.ejim.2021.08.010"},{"key":"869_CR45","doi-asserted-by":"crossref","unstructured":"Axelrad, J. E., Lichtiger, S. & Yajnik, V. Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment. World J. Gastroenterol. 22, 4794\u20134801 (2016).","DOI":"10.3748\/wjg.v22.i20.4794"},{"key":"869_CR46","doi-asserted-by":"publisher","first-page":"107752","DOI":"10.1016\/j.jbc.2024.107752","volume":"300","author":"AD Silva","year":"2024","unstructured":"Silva, A. D., Hwang, J., Marciel, M. P. & Bellis, S. L. The pro-inflammatory cytokines IL-1\u03b2 and IL-6 promote upregulation of the ST6GAL1 sialyltransferase in pancreatic cancer cells. J. Biol. Chem. 300, 107752 (2024).","journal-title":"J. Biol. Chem."},{"key":"869_CR47","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1136\/gutjnl-2012-303329","volume":"63","author":"M Bersudsky","year":"2014","unstructured":"Bersudsky, M. et al. Non-redundant properties of IL-1\u03b1 and IL-1\u03b2 during acute colon inflammation in mice. Gut 63, 598\u2013609 (2014).","journal-title":"Gut"},{"key":"869_CR48","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41577-024-01075-9","volume":"25","author":"RC Coll","year":"2025","unstructured":"Coll, R. C. & Schroder, K. Inflammasome components as new therapeutic targets in inflammatory disease. Nat. Rev. Immunol. 25, 22\u201341 (2025).","journal-title":"Nat. Rev. Immunol."},{"key":"869_CR49","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41575-025-01141-0","volume":"23","author":"J Schw\u00e4rzler","year":"2026","unstructured":"Schw\u00e4rzler, J., Menghini, P., Dinarello, C., Cominelli, F. & Tilg, H. IL-1 family of cytokines in gastrointestinal and liver disorders. Nat. Rev. Gastroenterol. Hepatol. 23, 29\u201343 (2026).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"869_CR50","doi-asserted-by":"crossref","unstructured":"Bulek, K. et al. Epithelial-derived gasdermin D mediates nonlytic IL-1\u03b2 release during experimental colitis. J. Clin. Invest. 130, 4218\u20134234 (2020).","DOI":"10.1172\/JCI138103"},{"key":"869_CR51","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1111\/apt.12500","volume":"38","author":"E Richman","year":"2013","unstructured":"Richman, E. & Rhodes, J. M. Review article: evidence-based dietary advice for patients with inflammatory bowel disease. Aliment Pharm. Ther. 38, 1156\u20131171 (2013).","journal-title":"Aliment Pharm. Ther."},{"key":"869_CR52","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1111\/j.1572-0241.2007.01411.x","volume":"102","author":"DK Amre","year":"2007","unstructured":"Amre, D. K. et al. Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for crohn\u2019s disease in children. Am. J. Gastroenterol. 102, 2016\u20132025 (2007).","journal-title":"Am. J. Gastroenterol."},{"key":"869_CR53","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/00054725-200502000-00009","volume":"11","author":"N Sakamoto","year":"2005","unstructured":"Sakamoto, N. et al. Dietary risk factors for inflammatory bowel disease - A multicenter case-control study in Japan. Inflamm. Bowel Dis. 11, 154\u2013163 (2005).","journal-title":"Inflamm. Bowel Dis."},{"key":"869_CR54","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3516128","volume":"2020","author":"D Zhao","year":"2020","unstructured":"Zhao, D. et al. High-fat diet promotes DSS-induced ulcerative colitis by downregulated FXR expression through the TGFB pathway. Biomed. Res Int-Uk 2020, 3516128 (2020).","journal-title":"Biomed. Res Int-Uk"},{"key":"869_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2020.1819155","volume":"12","author":"LY Wang","year":"2020","unstructured":"Wang, L. Y. et al. Gut microbial bile acid metabolite skews macrophage polarization and contributes to high-fat diet-induced colonic inflammation. Gut Microbes 12, 1\u201320 (2020).","journal-title":"Gut Microbes"},{"key":"869_CR56","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/advances\/nmz061","volume":"11","author":"MW Rohr","year":"2020","unstructured":"Rohr, M. W., Narasimhulu, C. A., Rudeski-Rohr, T. A. & Parthasarathy, S. Negative effects of a high-fat diet on intestinal permeability: A review. Adv. Nutr. 11, 77\u201391 (2020).","journal-title":"Adv. Nutr."},{"key":"869_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13997","volume":"8","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. Saturated palmitic acid induces myocardial inflammatory injuries through direct binding to TLR4 accessory protein MD2. Nat. Commun. 8, 13997 (2017).","journal-title":"Nat. Commun."},{"key":"869_CR58","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1038\/s41418-020-00668-w","volume":"28","author":"L Tao","year":"2021","unstructured":"Tao, L. et al. RIP1 kinase activity promotes steatohepatitis through mediating cell death and inflammation in macrophages. Cell Death Differ. 28, 1418\u20131433 (2021).","journal-title":"Cell Death Differ."},{"key":"869_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-08111-z","volume":"16","author":"L Hern\u00e1ndez-Torres","year":"2025","unstructured":"Hern\u00e1ndez-Torres, L. et al. HERPUD1 mediates palmitic acid-induced UPR sustaining TNBC aggressiveness and is destabilized by CK2 pharmacological inhibition. Cell Death Dis. 16, 793 (2025).","journal-title":"Cell Death Dis."},{"key":"869_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2016.157","volume":"49","author":"LD Ly","year":"2017","unstructured":"Ly, L. D. et al. Oxidative stress and calcium dysregulation by palmitate in type 2 diabetes. Exp. Mol. Med. 49, e291 (2017).","journal-title":"Exp. Mol. Med."},{"key":"869_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05003-4","volume":"13","author":"S Saha","year":"2022","unstructured":"Saha, S. et al. Proteomic analysis reveals USP7 as a novel regulator of palmitic acid-induced hepatocellular carcinoma cell death. Cell Death Dis. 13, 563 (2022).","journal-title":"Cell Death Dis."},{"key":"869_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34993-0","volume":"13","author":"L Yan","year":"2022","unstructured":"Yan, L. et al. SENP1 prevents steatohepatitis by suppressing RIPK1-driven apoptosis and inflammation. Nat. Commun. 13, 7153 (2022).","journal-title":"Nat. Commun."},{"key":"869_CR63","doi-asserted-by":"publisher","first-page":"4419","DOI":"10.1016\/j.molcel.2024.10.002","volume":"84","author":"N Zhang","year":"2024","unstructured":"Zhang, N. et al. Palmitoylation licenses RIPK1 kinase activity and cytotoxicity in the TNF pathway. Mol. Cell 84, 4419\u20134435.e4410 (2024).","journal-title":"Mol. Cell"},{"key":"869_CR64","doi-asserted-by":"crossref","unstructured":"Zhang, N. et al. A palmitoylation\u2013depalmitoylation relay spatiotemporally controls GSDMD activation in pyroptosis. Nat. Cell Biol. 26, 757\u2013769 (2024).","DOI":"10.1038\/s41556-024-01397-9"}],"container-title":["Cell Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41421-026-00869-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41421-026-00869-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41421-026-00869-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T17:13:19Z","timestamp":1771434799000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41421-026-00869-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["869"],"URL":"https:\/\/doi.org\/10.1038\/s41421-026-00869-6","relation":{},"ISSN":["2056-5968"],"issn-type":[{"value":"2056-5968","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]},"assertion":[{"value":"5 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}